記憶度
9問
21問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
Complementary relationship between the drug molecule and its active site
Induced fit theory.
2
maximum biological effect resulting from a drug binding to its target
Efficacy/ intrinsic activity.
3
Cocoaine.
Plant kingdome.
4
Cephalosporin.
Microbiological world
5
Special consideration is given on Orphan drugs (treatment IND) • orphan drug is used to treat orphan disease, or disease that affects fewer than 200,000 people in the US
IND.
6
Post-marketing studies and manufacturing scale-up activities take place
Phase 4.
7
These studies also evaluate drug metabolism, structure-activity relationships, and the mechanism of action in humans.
Phase 1.
8
the intensity of the pharmacologic activity of a structurally specific drug is directly proportional to the number of receptors occupied by the drug
Occupational theory of response.
9
The target cells become desensitized and the effect of subsequent exposure to the same concentration of the drug is reduced.
Desensitization.
10
What is the opiate u receptors antagonist
Naloxone.
11
Large libraries of compounds are tested for their ability to modify the target capable of examining 15,000 chemical compounds a week using 10 – 20 bioassays.
High throughput screening.
12
Protein.
Animal source.
13
Quinine
Plant kingdom.
14
Permit to market drug product
NDA.
15
an increasing number of new receptors and enzymes potential drug targets
Genome project.
16
drugs activity is tested on isolated tissues, cells, enzymes.
In vitro test.
17
Somatostatin. (protein)
Animal source.
18
Modification of drug formulation as obtained from manufacturing scale-up and validation process may be done
Phase 4.
19
A popular term for a generic drug with an identical formulation and stated indications as a drug previously approved by the FDA.
Me-too-Drugs.
20
Glucagon (Protein)
Animal source.
21
vaccines (living or killed microorganisms)
Biological sources
22
1000-3000 with the target illness.
Phase 3
23
Conduct short-term toxicity studies ranging from 2 weeks to 3 months.
At preclinical stage.
24
The study of the interaction of the drugs with cells.
Pharmacodynamics.
25
100-300 Suffer from the target illness
Phase 2.
26
Aminoglycosides.
Microbial world.
27
Submitted to FDA à Review by FDA for 30 days
IND.
28
Penicillin.
Microbiological world.
29
• Failure during Phase II testing is common • After phase 2, sponsors meet with the FDA (True/False)
True
30
This phase of testing also helps determine the common short-term side effects and risks associated with the drug.
Phase 2.
31
What is B1-adrenoceptors Agonist
Isoprenaline.
32
Amphotericin B.
Lipid.
33
Tetracycline.
Microbiological world.
34
These studies also provide an adequate basis for extrapolating the results to the general population and transmitting that information in the physician labeling
Phase 3.
35
Prewingkle
Plant kingdom.
36
Cell or group of cells specialized to detect changes in the environment and trigger impulses in the sensory nervous system
Receptors.
37
Reserpine.
Plant kingdom.
38
a molecule that binds to a receptor
Ligand.
39
Generic drug . A company needs to show the FDA that the drug is bioequivalent to the innovator drug
NDA.
40
completely complementary relationship between the drug molecule and a specific area on the surface of the receptor molecule
Lock and key theory.
41
Heparin (Polysaccharide)
Animal source.
42
What is the opiate u receptors agonist
Morphine.
43
Bile acids.
Animal source.
44
Filed before drug may be given to human (clinical trials)
IND.
45
In. vitro and in vivo testing, determination of LD 50.
Toxicity testing.
46
Lovastatin.
Microbiological world.
47
Dating back to the cavemen following their instincts to survive or preserve their lives, drugs already exist in various forms.
Drug discover before.
48
Focusing on the financial return
1.
49
Used as receptors.
Protein.
50
An increased-concentration of the drug is required to produce an effect of the same magnitude as the initial exposure with a smaller drug concentration (T/F)
True.
51
A compound showing a desired pharmacological property which can be used to initiate a medicinal chemistry project
Finding a lead compound.
52
What is the H1 and H2 receptors agonist
Histamine.
53
What is B2-adrenoceptors Agonist.
Salbutamol.
54
Safety and effectiveness
Phase 2.
55
The general area of study concerned with the formulation, manufacturing, stability, and effectiveness of a pharmaceutical dosage form
Pharmaceuticals.
56
Dynamic interactions between drug molecules and cellular components
Drug action.
57
The handling of a drug within the body. it includes the adme process.
Pharmacokinetics.
58
Protein catalysts are produced by living cells by acting as a surface or focus for the reaction, bringing the substrate(s) together and holding them in the best position for the reaction.
Enzyme.
59
These studies are intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug.
Phase 3.
60
20-80 healthy volunteer.
Phase 1.
61
submitted for review and approval after the completion of the clinical trials and requirements have been met
NDA.
62
inducing a clinical condition and treated with the test drug
In vivo test.
63
What is the H1 receptors antagonist
Mepyramine.
64
DNA and RNA acting as a drug target.
Nucleic acids target.
65
Even before the synthetic, target-based, and selective medicinal agents, remedies were abundantly provided by various plant sources more commonly referred to as herbal remedies
Drug development before.
66
What is B2-adrenoceptors Antagonist
Propanolol.
67
Result of downregulation
Desensitization.
68
Used as molecular tag.
Carbohydrates.
69
For safety
Phase 1
70
Science of the properties of the drugs and it's effect in the body.
Pharmacology.
71
Paclitaxel.
Plant kingdom.
72
atoms and functional groups required for a specific pharmacological activity, and their relative positions in space
Pharmacophore.
73
Estrogens.
Animal source.
74
Safety, effectiveness and dosage
Phase 3.
75
What is the H2 receptors antagonist
Ranitidine.
76
What is B1-adrenoceptors Antagonist
Atenolol
77
Morphine
Plant kingdom.
78
Ways of discovering a lead compound
Finding a lead compound.
79
Caused by continuous prolonged exposure of receptors to drugs that disrupt the homeostatic equilibrium and result in altered levels of the receptors.
Down regulation.
80
In vivo and in vitro.
Identifying bioassay.
81
Receptors, enzymes, and nucleic acids
2.
82
Filed before drug may be given to human (clinical trials)
Investigational new drug application.
83
These studies are designed to determine the metabolic and pharmacological actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness
Phase 1.
84
measure of how strongly a drug binds to a receptor
Affinity.
85
The DISCOVERY phase includes synthesis, isolation, fermentation, screening, and SAR studies
Drug development process.
86
Protein in nature and embedded in the cell membrane
Receptors.
87
Chemical and physical characterization, pharmacology, pharmacokinetics, pharmacodynamics, pharmaceutics, analytical studies, toxicology
Pre clinical studies.